Xanadu Bio is a nanoparticle delivery company focusing on the delivery of mRNA and other nucleic acids that uses PACE platform technology.
Xanadu Bio has raised $11.0M in total funding. The most recent round was Series B. The last funding was announced in September 2025.
Xanadu Bio is headquartered in Gladwyne, United States.
Xanadu Bio is a nanoparticle delivery company focusing on the delivery of mRNA and other nucleic acids that uses PACE platform technology.
Xanadu Bio is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Xanadu Bio — Funding & Investors." VCBacked, September 15, 2025, https://www.vcbacked.co/company/xanadu-bio. Accessed August 1, 2026.
VCBacked. (2025). Xanadu Bio — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/xanadu-bio
{{cite web |title=Xanadu Bio — Funding & Investors |url=https://www.vcbacked.co/company/xanadu-bio |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated